These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15984986)

  • 1. Positive predictive value of fecal occult blood testing in persons taking warfarin.
    Bini EJ; Rajapaksa RC; Weinshel EH
    Am J Gastroenterol; 2005 Jul; 100(7):1586-92. PubMed ID: 15984986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
    Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
    N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal occult blood test performance indicators in warfarin-treated patients.
    Kershenbaum A; Lavi I; Rennert G; Almog R
    Dis Colon Rectum; 2010 Feb; 53(2):224-9. PubMed ID: 20087099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens.
    Bini EJ; Kinkhabwala A; Goldfarb DS
    Am J Kidney Dis; 2006 Oct; 48(4):580-6. PubMed ID: 16997054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-deficiency anemia due to chronic gastrointestinal bleeding.
    Reyes López A; Gómez Camacho F; Gálvez Calderón C; Miño Fugarolas G
    Rev Esp Enferm Dig; 1999 May; 91(5):345-58. PubMed ID: 10362876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
    Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
    Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?
    Gandhi S; Narula N; Gandhi S; Marshall JK; Farkouh ME
    J Gastroenterol Hepatol; 2013 Jun; 28(6):931-6. PubMed ID: 23517228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening.
    Clarke P; Jack F; Carey FA; Steele RJ
    Colorectal Dis; 2006 Jun; 8(5):389-92. PubMed ID: 16684082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission.
    Scales CD; Fein S; Muir AJ; Rockey DC
    J Clin Gastroenterol; 2006; 40(10):913-8. PubMed ID: 17063111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal occult blood testing for colorectal cancer screening: use the finger.
    Burke CA; Tadikonda L; Machicao V
    Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients.
    Hisamuddin K; Mowat NA; Phull PS
    Dig Liver Dis; 2006 Jul; 38(7):503-7. PubMed ID: 16522381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Sakaguchi K; Shiratori Y
    Am J Gastroenterol; 2007 Oct; 102(10):2259-64. PubMed ID: 17617203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional endoscopy in patients with fecal occult blood.
    Velez JP; Schwesinger WH; Stauffer J; Gaskill HV; Kazantsev GB; Sirinek KR; Strodel WE
    Surg Endosc; 2002 Jan; 16(1):117-20. PubMed ID: 11961620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
    Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
    Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy?
    Chen YK; Gladden DR; Kestenbaum DJ; Collen MJ
    Am J Gastroenterol; 1993 Dec; 88(12):2026-9. PubMed ID: 8249968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An audit of the utility of in-patient fecal occult blood testing.
    Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW
    Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.